Fig. 3From: Biosimilar filgrastim treatment patterns and prevention of febrile neutropenia: a prospective multicentre study in France in patients with solid tumours (the ZOHé study)Characteristics of severe (grade 3–4) neutropenia episodes (n = 105) in the ST population during the study. GI, gastrointestinal; GYN, gynaecologicalBack to article page